Single Dose of Cindamycin Could Increase Vulnerability to C. Difficile

Researchers from Memorial Sloan-Kettering Cancer Center in New York City administered a single dose of clindamycin to a group of mice and found surviving mice remained susceptible to C. difficile infection for at least 28 days, according to research published in Infection and Immunity.

Advertisement
Jaimie Oh

Read the full report in Becker’s Hospital Review on C. difficile.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.